Abstract
Tin-mesoporphyrin (SnMP) is a competitive inhibitor of microsomal heme oxygenase (the rate-limiting enzyme in the heme catabolic pathway). It was administered as a single intramuscular dose at 46 hours of life to a very-low-birth-weight infant with severe hemolytic hyperbilirubinemia who had been awaiting an exchange transfusion. This case documents the effective elimination of the need for an exchange transfusion in a very-low-birth-weight infant and is a confirmation of the experience of others for the use of SnMP in reducing bilirubin production.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A . Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 1994;93:1–11.
Kappas A, Drummond GS, Henschke C, Valaes T . Direct comparison of Sn-mesoporphyrin an inhibitor of bilirubin production and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics 1995;95:468–474.
Kappas A, Drummond GS, Munson DP, Marshall JR . Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics 2001;108:1374–1377.
Kappas A, Drummond GS, Valaes T . A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001;108:25–30.
Galbraith RA, Drummond GS, Kappas A . Suppression of bilirubin production in the Crigler–Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin. Pediatrics 1992;89:175–182.
Rubaltalli FF, Dario C, Zancan L . Congenital nonobstructive, nonhemolytic jaundice: effect of tin-mesoporphyrin. Pediatrics 1994;95:942–944.
Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T . Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 1988;81:485–497.
Maisels MJ . Neonatal jaundice. In: Avery GB, Fletcher MA, MacDonald M, editors. Neonatology: Pathophysiology and Management of the Newborn. Philadelphia, PA: JB Lippincott; 1994.
Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A . Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1999;108:25–30.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reddy, P., Najundaswamy, S., Mehta, R. et al. Tin-mesoporphyrin in the Treatment of Severe Hyperbilirubinemia in a Very-low-birth-weight Infant. J Perinatol 23, 507–508 (2003). https://doi.org/10.1038/sj.jp.7210943
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210943
This article is cited by
-
Chemoprevention of bilirubin encephalopathy with a nanoceutical agent
Pediatric Research (2023)
-
Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?
Journal of Perinatology (2021)
-
Targeted suppression of heme oxygenase-1 by small interference RNAs inhibits the production of bilirubin in neonatal rat with hyperbilirubinemia
BMC Molecular Biology (2009)